Page last updated: 2024-08-25

guluronic acid and Multiple Sclerosis, Relapsing-Remitting

guluronic acid has been researched along with Multiple Sclerosis, Relapsing-Remitting in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Asarzadegan, F; Azizi, G; Farokhfar, M; Hossein-Khannazer, N; Mirshafeiey, A; Safarpour Lima, B; Shabani, S	1

Other Studies

1 other study(ies) available for guluronic acid and Multiple Sclerosis, Relapsing-Remitting

Article	Year
Pivotal cytokines and their transcription factors are the targets of guluronic acid (G2013) for inhibiting the immunopathogenesis process of multiple sclerosis. Drug development research, 2020, Volume: 81, Issue:4 Topics: Adult; Case-Control Studies; Cytokines; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Hexuronic Acids; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Transcription Factors; Young Adult	2020

Article

Year

Pivotal cytokines and their transcription factors are the targets of guluronic acid (G2013) for inhibiting the immunopathogenesis process of multiple sclerosis.

Drug development research, 2020, Volume: 81, Issue:4

Topics: Adult; Case-Control Studies; Cytokines; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Hexuronic Acids; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Transcription Factors; Young Adult

2020